1
|
Variability in peripheral blood enrichment techniques can alter equine leukocyte cellularity, viability and function. Vet Immunol Immunopathol 2020; 225:110062. [PMID: 32438246 DOI: 10.1016/j.vetimm.2020.110062] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2019] [Revised: 03/12/2020] [Accepted: 05/09/2020] [Indexed: 11/21/2022]
Abstract
Peripheral blood is commonly sampled to assess the health status of human and veterinary patients. Venous blood collection is a minimally invasive procedure, and in the horse, the common collection site is the jugular vein. Post blood collection, sample processing for leukocyte enrichment can vary by research laboratory with the potential to yield different effects on the enriched cells and their function. The focus of the present study was to compare a common blood dilution-leukocyte enrichment technique using a Histopaque gradient medium (His) to a modified leukocyte buffy coat syringe-lymphocyte separation medium technique (Syr- LSM) with peripheral blood from 12 healthy horses. The endpoints examined included cell recovery/mL of blood, cell viability, leukocyte enrichment purity, leukocyte cell marker subset phenotype, leukocyte spontaneous and mitogen-induced proliferation and secretory TNFα concentrations. Leukocyte cell recovery/mL of whole blood and cell viability was significantly increased in enriched leukocytes from the Syr-LSM technique. Interestingly, the percentage of CD8+ and CD21+ were significantly increased with the His technique as was Con A-induced proliferation. Still, leukocyte cell purity and TNFα concentrations from the 72 h cell culture supernatants were comparable across the two enrichment techniques. To summarize, the type of whole blood leukocyte enrichment technique employed can affect the results of immunologic assay endpoints possibly altering data interpretation.
Collapse
|
2
|
French H, Peterson E, Schulman M, Roth R, Crampton M, Conan A, Marchi S, Knobel D, Bertschinger H. Efficacy and safety of native and recombinant zona pellucida immunocontraceptive vaccines in donkeys. Theriogenology 2020; 153:27-33. [PMID: 32417608 DOI: 10.1016/j.theriogenology.2020.04.041] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2019] [Revised: 04/13/2020] [Accepted: 04/30/2020] [Indexed: 11/18/2022]
Abstract
Feral and semi-feral donkeys are recognised as a problem in some world regions. The main problem associated with uncontrolled donkey populations is habitat degradation and competition for feed resources, especially in arid climes. Controlling population numbers would reduce the impact of donkeys and other species. While removal by various means is effective, it has been shown to stimulate reproductive rate. Probably the most effective and humane solution is reducing reproduction using minimally invasive methods including immunocontraception. This study tested the immunocontraceptive efficacy and safety of zona pellucida (ZP) vaccines, both recombinant (reZP; three treatments) and native porcine (pZP; two treatments) vaccines formulated with Freund's modified complete (primary) and Freund's incomplete (boosters) adjuvants in donkey jennies. Control jennies received adjuvants only (two treatments). Twenty-five non-pregnant jennies were randomly assigned to reZP (n = 9), pZP (n = 8) or control (n = 8) groups. Weekly monitoring of the reproductive tract and ovaries via transrectal palpation and ultrasound and inspection of injection sites was conducted and anti-pZP antibody titers were measured. Five weeks after last treatment, one donkey jack was introduced to each group and rotated every 21 days. By 232 days after last treatment the number pregnant and median days to pregnancy was 2/9 and 214 (reZP group), 1/8 and 196 (pZP group) and 8/8 and 77 (control group). Median time to ovarian shut-down was 77 (9/9) and 56 (7/8) days for reZP and pZP groups, respectively. This was observed in association with a distinct reduction in mean uterine diameter. The antibody response was equally good for both ZP-treated groups. Incorporation of Freund's adjuvants initially produced a high incidence of side effects from local swelling and intermittent lameness followed weeks later by sterile abscesses (reZP, 9/9; pZP, 7/8; control, 3/8). Both ZP vaccines effectively controlled reproduction in jennies, albeit with a high incidence of adjuvant-associated side effects.
Collapse
Affiliation(s)
- Hilari French
- Ross University School of Veterinary Medicine, PO Box 334, Basseterre, St Kitts, West Indies.
| | - Erik Peterson
- Ross University School of Veterinary Medicine, PO Box 334, Basseterre, St Kitts, West Indies.
| | - Martin Schulman
- Veterinary Population Management Laboratory, Section of Reproduction, Department of Production Animal Studies, Faculty of Veterinary Science, University of Pretoria, South Africa.
| | - Robyn Roth
- Council for Scientific and Industrial Research, Pretoria, South Africa.
| | - Michael Crampton
- Council for Scientific and Industrial Research, Pretoria, South Africa.
| | - Anne Conan
- Ross University School of Veterinary Medicine, PO Box 334, Basseterre, St Kitts, West Indies.
| | - Silvia Marchi
- Ross University School of Veterinary Medicine, PO Box 334, Basseterre, St Kitts, West Indies.
| | - Darryn Knobel
- Ross University School of Veterinary Medicine, PO Box 334, Basseterre, St Kitts, West Indies; Department of Veterinary Tropical Diseases, University of Pretoria, South Africa.
| | - Henk Bertschinger
- Veterinary Population Management Laboratory, Section of Reproduction, Department of Production Animal Studies, Faculty of Veterinary Science, University of Pretoria, South Africa.
| |
Collapse
|
3
|
Joonè CJ, Nolan MB, Bertschinger HJ, Schulman ML. Researching immunocontraceptive vaccines with mares (Equus caballus) as both a target and model for African elephant (Loxodonta africana) cows: A review. Anim Reprod Sci 2019; 207:146-152. [PMID: 31208844 DOI: 10.1016/j.anireprosci.2019.06.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2019] [Revised: 05/30/2019] [Accepted: 06/02/2019] [Indexed: 10/26/2022]
Abstract
A sequence of studies is reviewed that reported the domestic horse (Equus caballus) mare as an appropriate and accessible research platform for recording clinical and laboratory data post-immunisation with anti- GnRH and -zona pellucida (ZP) immunocontraceptive vaccines. Experience with a native porcine ZP (pZP) vaccine in African elephant (Loxodonta africana) cows highlighted needs for improving vaccine formulations and more clearly defining associated ovarian effects and safety profiles. Initially, the efficacy, reversibility and safety of the GnRH vaccine Improvac® in mares was demonstrated using reproductive tract ultrasonography and concurrently measuring serum antibody titres and progesterone concentrations. Results informed the study design and minimally invasive monitoring of post-treatment ovarian steroid responses of this vaccine in free-ranging African elephant cows. A subsequent sequence of studies reported reversible contraceptive and immunological efficacy in pony mares immunised with pZP formulated with Freund's adjuvants. By comparison, mares treated with a recombinant ZP3 and ZP4 (reZP) vaccine showed disappointing responses. Unexpectedly, most pZP-treated mares showed ovarian inactivity. In attempting to understand this response, results showed the involvement of cytotoxic (CD8+) T-cells negatively correlated to serum ovarian steroid and anti-Müllerian hormone (AMH) levels. Of concern was the prevalence of injection-site lesions ascribable to Freund's adjuvants. Following this, mares treated with both pZP and a novel reZP vaccine formulated with non-Freund's adjuvants showed comparable immunological responses and ovarian inactivity, notably without adverse treatment reactions. In addition, measuring AMH showed promise for monitoring ovarian function in anti-ZP-treated animals.
Collapse
Affiliation(s)
- Carolynne J Joonè
- College of Public Health, Medical & Veterinary Sciences, James Cook University, Australia.
| | - Margaret B Nolan
- Section of Reproduction, Faculty of Veterinary Science, University of Pretoria, South Africa.
| | - Henk J Bertschinger
- Section of Reproduction, Faculty of Veterinary Science, University of Pretoria, South Africa.
| | - Martin L Schulman
- Section of Reproduction, Faculty of Veterinary Science, University of Pretoria, South Africa.
| |
Collapse
|
4
|
Nolan MB, Schulman ML, Botha AE, Human AM, Roth R, Crampton MC, Bertschinger HJ. Serum antibody immunoreactivity and safety of native porcine and recombinant zona pellucida vaccines formulated with a non-Freund’s adjuvant in horses. Vaccine 2019; 37:1299-1306. [DOI: 10.1016/j.vaccine.2019.01.053] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2018] [Revised: 01/16/2019] [Accepted: 01/18/2019] [Indexed: 01/01/2023]
|